ArticlePloS one2012

Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage.

Paul W Fenimore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.